C-399T Polymorphism in the Promoter Region of Human Tissue Factor Pathway Inhibitor (TFPI) Gene Does not Change the Plasma TFPI Antigen Level and Does not Cause Venous Thrombosis

Toshiyuki Miyata; Toshiyuki Sakata; Kousuke Kumeda; Kagehiro Uchida; Motoo Tsushima; Hironobu Fujimura; Tomio Kawasaki; Hisao Kato

doi:10.1055/s-0037-1615202

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1998; 80(02): 345-346
DOI: 10.1055/s-0037-1615202

Letters to the Editor

Schattauer GmbH

C-399T Polymorphism in the Promoter Region of Human Tissue Factor Pathway Inhibitor (TFPI) Gene Does not Change the Plasma TFPI Antigen Level and Does not Cause Venous Thrombosis

Toshiyuki Miyata

¹Research Institute

,

Toshiyuki Sakata

²Department of Clinical Laboratory

,

Kousuke Kumeda

³Chemo-Sero-Therapeutic Research Institute, Kumamoto

,

Kagehiro Uchida

⁴FALCO Bio Systems Ltd, Kuze-gun, Kyoto

,

Motoo Tsushima

⁵Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka

,

Hironobu Fujimura

⁶Department of Surgery II, Osaka University Medical School, Suita, Japan

,

Tomio Kawasaki

⁶Department of Surgery II, Osaka University Medical School, Suita, Japan

,

Hisao Kato

¹Research Institute

› Author Affiliations

Abstract

Full Text

References

References
1 Broze Jr GJ. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992; 29: 159-69.
2 Wun TC. Tissue factor pathway inhibitor. In: Molecular Basis of Thrombosis and Hemostasis. High KA, Roberts HR. (eds). Marcel Dekker; New York: 1995. pp 331-53.
3 van der Logt CPE, Reitsma PH, Bertina RM. Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: The factor Xa dependent inhibitor of the extrinsic pathway of coagulation. Biochemistry 1991; 30: 1571-7.
4 Girard TJ, Eddy R, Wesselschmidt RL, MacPhail LA, Likert KM, Byers MG, Shows TB, Broze Jr GJ. Structure of the human lipoprotein-associated coagulation inhibitor gene. Intron/exon gene organization and localization of the gene to chromosome 2. J Biol Chem 1991; 266: 5036-41.
5 Enjyoji K, Emi M, Mukai T, Imada M, Leppert ML, Lalouel JM, Kato H. Human tissue factor pathway inhibitor (TFPI) gene: Complete genomic structure and localization on the genetic map of chromosome 2q. Genomics 1993; 17: 423-8.
6 Maruyama C, Tsushima M, Kyotani S, Nakamori T, Fukushima S, Maruyama T. Cerebral blood flow velocity and serum fatty acid composition. Nutr Metab Cardiovasc Dis 1996; 6: 81-9.
7 Miyata T, Sakata T, Zheng YZ, Tsukamoto H, Umeyama H, Uchiyama S, Ikusaka M, Yoshioka A, Imanaka Y, Fujimura H, Kambayashi J, Kato H. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-stand conformational polymorphism analysis and a model building. Thromb Haemost 1996; 76: 302-11.
8 Kamikura Y, Wada H, Yamada A, Shimura M, Hiyoyama K, Shiku H, Tanigawa M, Nishikawa H, Yamada N, Isaka N, Nakano T, Kumeda K, Kato H. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. Am J Hematol 1997; 55: 183-7.